Search
  1. Home
  2. Africa

Drug company millions pledged for AIDS

    JOHANNESBURG

    Multinational drug manufacturer, GlaxoSmithKline (GSK) has announced a US $1.6 million grant over 2 years to support an HIV/AIDS clinic in Malawi and another in Uganda.

    In a recent statement, GSK said the grant was part of the company's long-standing commitment to health initiatives in the developing world, and care and community assistance for people living with HIV/AIDS.

    The president of GSK's US operations, Chris Viehbacher, explained that the grant aimed to improve the standard of medical care provided to families, while also promoting community awareness and HIV/AIDS education.

    Viehbacher said: "We hope this GSK grant will help support care for the whole family ... if the family's HIV health is addressed, both parents will live longer, so that the child will be cared for."

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join